{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:05:22Z","timestamp":1761843922541},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.lpm.2009.10.010","type":"journal-article","created":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T10:09:12Z","timestamp":1259834952000},"page":"93-106","source":"Crossref","is-referenced-by-count":4,"title":["Sarco\u00efdose m\u00e9diastinopulmonaire"],"prefix":"10.1016","volume":"39","author":[{"given":"Hilario","family":"Nunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurdagul","family":"Uzunhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Freynet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Naccache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Bouvry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Brillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2009.10.010_bib1","unstructured":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736-55."},{"key":"10.1016\/j.lpm.2009.10.010_bib2","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1398-9995.2005.00778.x","article-title":"Pulmonary sarcoidosis","volume":"60","author":"Nunes","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.lpm.2009.10.010_bib4","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1378\/chest.121.1.32","article-title":"Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy","volume":"121","author":"Reich","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2009.10.010_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1378\/chest.124.3.922","article-title":"Predicting mortality in patients with sarcoidosis awaiting lung transplantation","volume":"124","author":"Shorr","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2009.10.010_bib7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/thx.43.7.516","article-title":"Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease","volume":"43","author":"Valeyre","year":"1988","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2009.10.010_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"Lofgren's syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1164\/rccm.200303-456OC","article-title":"C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome","volume":"168","author":"Spagnolo","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib11","doi-asserted-by":"crossref","unstructured":"Sato H, Williams HR, Spagnolo P, Abdallah A., Ahmad T., Orchard TR et al. CARD15\/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis. Eur Respir J 2009; 0:09031936.00010209v1.","DOI":"10.1183\/09031936.00010209"},{"key":"10.1016\/j.lpm.2009.10.010_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2007-970336","article-title":"Imaging in sarcoidosis","volume":"28","author":"Nunes","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1148\/radiology.191.2.8153310","article-title":"Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis","volume":"191","author":"Grenier","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.lpm.2009.10.010_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/thx.2008.105031","article-title":"Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis?","volume":"64","author":"de Boer","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2009.10.010_bib15","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1183\/09031936.97.10122699","article-title":"CD4\/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis?","volume":"10","author":"Costabel","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2009.10.010_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1378\/chest.08-2768","article-title":"A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis","volume":"136","author":"Tremblay","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2009.10.010_bib17","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1378\/chest.125.6.2061","article-title":"Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange","volume":"125","author":"Lamberto","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2009.10.010_bib18","first-page":"143","article-title":"18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab","volume":"25","author":"Keijsers","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.lpm.2009.10.010_bib19","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2009.10.010_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1164\/rccm.200608-1197OC","article-title":"Sex-specific manifestations of Lofgren's syndrome","volume":"175","author":"Grunewald","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9343(99)00223-5","article-title":"Lofgren's syndrome revisited: a study of 186 patients","volume":"107","author":"Mana","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib22","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2214\/ajr.174.6.1741751","article-title":"Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function","volume":"174","author":"Abehsera","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.lpm.2009.10.010_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.93.06030349","article-title":"Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage","volume":"6","author":"Viskum","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2009.10.010_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/RCT.0b013e31815b63dd","article-title":"High-resolution computed tomographic imaging of airways in sarcoidosis patients with airflow obstruction","volume":"32","author":"Naccache","year":"2008","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.lpm.2009.10.010_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2009.10.010_bib26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1378\/chest.08-1881","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience","volume":"135","author":"Barnett","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2009.10.010_bib27","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1183\/09031936.06.00112205","article-title":"Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients","volume":"27","author":"Muller-Quernheim","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2009.10.010_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1164\/rccm.200607-1042OC","article-title":"Recent chronic beryllium disease in residents surrounding a beryllium facility","volume":"177","author":"Maier","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.md.0000157577.69729.e6","article-title":"Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2009.10.010_bib30","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(09)61057-6","article-title":"Silica in oral drugs as a possible sarcoidosis-inducing antigen","volume":"373","author":"Sola","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2009.10.010_bib31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/thx.2006.062836","article-title":"Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"61","author":"Gribbin","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2009.10.010_bib32","first-page":"154","article-title":"Predicting respiratory failure in sarcoidosis patients","volume":"14","author":"Baughman","year":"1997","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.lpm.2009.10.010_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","article-title":"British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment","volume":"51","author":"Gibson","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2009.10.010_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.121.1.24","article-title":"Early treatment of stage II sarcoidosis improves 5-year pulmonary function","volume":"121","author":"Pietinalho","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2009.10.010_bib35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.10.010_bib36","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209004916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209004916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T19:27:44Z","timestamp":1685215664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498209004916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0755498209004916"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2009.10.010","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}